EC
EVLO

EcoR1 Capital’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

EcoR1 Capital’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,021
Closed -$423K – 89
2022
Q2 		$423K Buy
+10,021
New +$465K 0.01% 76
2020
Q3 		– Sell
-62,500
Closed -$6.13M – 62
2020
Q2 		$6.13M Buy
+62,500
New +$5.47M 0.45% 32

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EcoR1 Capital's EVLO Position: Q3 2022 in Review

EcoR1 Capital sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2022, closing a stake of 10,021 shares — an estimated $423K sold.

EcoR1 Capital first reported a position in EVLO in Q2 2020 and held it in 2 quarters. The position peaked at $6.13M in Q2 2020. 41 funds tracked by Wall St. Rank hold EVLO as of Q3 2022.

  • EcoR1 Capital reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • EcoR1 Capital sold 10,021 Evelo Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $423K.
  • EcoR1 Capital first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • EcoR1 Capital's Evelo Biosciences, Inc. Common Stock position peaked at $6.13M in Q2 2020.
  • 41 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2022.

Based on EcoR1 Capital's 13F filing for Q3 2022, filed 14 Nov 2022.